Results 191 to 200 of about 71,439 (210)

Erlotinib

Reactions Weekly, 2014
openaire   +1 more source

Efficacy of bevacizumab plus erlotinib versus erlotinib alone in advanced non-small-cell lung cancer after failure of standard first-line chemotherapy (BeTa): a double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2011
John D Hainsworth
exaly  

Erlotinib efficacy and cerebrospinal fluid concentration in patients with lung adenocarcinoma developing leptomeningeal metastases during gefitinib therapy

Cancer Chemotherapy and Pharmacology, 2011
Takeshi Masuda, Shinichiro Ohshimo
exaly  

Nivolumab Plus Erlotinib in Patients With EGFR-Mutant Advanced NSCLC

Journal of Thoracic Oncology, 2018
Scott Gettinger, Matthew D Hellmann, Hossein Borghaei Do   +2 more
exaly  

Phase II study of erlotinib as a salvage treatment for non-small-cell lung cancer patients after failure of gefitinib treatment

Annals of Oncology, 2008
Dong Ho Lee
exaly  

Maintenance erlotinib versus erlotinib at disease progression in patients with advanced non-small-cell lung cancer who have not progressed following platinum-based chemotherapy (IUNO study)

Lung Cancer, 2016
Yi-Long Wu
exaly  

Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy

Journal of Controlled Release, 2016
Yongju He, Can Zhang
exaly  

The UGT1A1∗28 polymorphism correlates with erlotinib’s effect on SN-38 glucuronidation

European Journal of Cancer, 2010
Yong Liu, Mark J Ratain
exaly  

Erlotinib

Reactions Weekly, 2019
openaire   +1 more source

Phase II trial of erlotinib in women with squamous cell carcinoma of the vulva

Gynecologic Oncology, 2012
Don S Dizon
exaly